Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE1
Public Health Consequences of Covid-19
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19
- Status
- WITHDRAWN
- Phase
- NA
The South Proxa-Rescue AndroCoV Trial Against COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Vitamin D Supplementation and Clinical Improvement in COVID-19
- Status
- COMPLETED
- Phase
- NA
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
- Status
- UNKNOWN
- Phase
- N/A
Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of Care
- Status
- COMPLETED
- Phase
- N/A
A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001
- Status
- UNKNOWN
- Phase
- PHASE1
Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2
- Status
- UNKNOWN
- Phase
- N/A
Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Prediction for Critical Outcomes of Patients With COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
- Status
- WITHDRAWN
- Phase
- PHASE3
Population-based Age-stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection in the Federation of Bosnia and Herzegovina
- Status
- UNKNOWN
- Phase
- N/A
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
- Status
- COMPLETED
- Phase
- N/A
Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination
- Status
- UNKNOWN
- Phase
- PHASE3
COVID-19 Severity and Psychiatric Morbidity
- Status
- COMPLETED
- Phase
- N/A